Related Experiment Video
Updated: Jul 9, 2025
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
99
Post-COVID-19 pulmonary fibrosis: An ongoing concern
1Department of Medicine, Pulmonary Unit, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Annals of Thoracic Medicine
|December 7, 2023
Summary
Post-COVID-19 pulmonary fibrosis is a significant concern for survivors, with risk factors including age, male sex, and disease severity. High-resolution CT aids diagnosis, and treatment involves antifibrotics or immunosuppressants.
Area of Science:
- Pulmonology
- Infectious Diseases
- Radiology
Background:
- Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to millions of deaths and overwhelmed healthcare systems globally.
- A significant number of COVID-19 survivors experience long-term health issues, known as post-COVID-19 sequelae, affecting various organ systems.
- Pulmonary fibrosis has emerged as a major post-COVID-19 complication, necessitating further investigation and management strategies.
Purpose of the Study:
- To highlight pulmonary fibrosis as a critical sequela of COVID-19.
- To identify risk factors associated with the development of post-COVID-19 pulmonary fibrosis.
- To discuss diagnostic modalities and current management approaches for this condition.
Main Methods:
- Review of emerging data and clinical observations regarding post-COVID-19 pulmonary fibrosis.
- Utilizing high-resolution computed tomography (HRCT) for diagnosing and assessing the extent of pulmonary fibrosis.
- Analysis of risk factors such as age, sex, and COVID-19 disease severity.
Main Results:
- Post-COVID-19 pulmonary fibrosis is a recognized complication in survivors.
- Age, male sex, and severe COVID-19 disease are identified as risk factors.
- HRCT is crucial for detailed diagnosis and evaluation of fibrosis patterns and extent.
- Similarities between post-COVID-19 pulmonary fibrosis and idiopathic pulmonary fibrosis are noted, requiring further research.
Conclusions:
- Pulmonary fibrosis is a significant long-term consequence of COVID-19.
- Effective management requires excluding other causes, assessing fibrosis extent, and considering physiological impairment.
- Treatment strategies may include immunosuppressants, antifibrotics, or a combination thereof.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
292
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
292
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:17Other Pulmonary Disorders
844
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
844
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.9K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.9K